Ann: Q4 FY24 Investor Presentation, page-10

I wouldn't say a waste of a webinar question. I asked 2 questions and both were answered. Once somewhat frazzled Doug which raised my eyebrow as it came across like he didn't know what it was, but somewhat did. He is ex Hologic and dealing specifically with that test. I would be surprised if he didnt have grapevine hearsay about expansion to Australia for the testing. The other about Febridx and Aus sales was to gauge whether there was any interest in the product immediately.

Lumos has been in the AUS market for some time and even appeared on the news when Covid occurred as they were going to establish a RAT test facility (didnt happen). I would have an assumption that they would have people here in the space who may be interested and jump onto orders as soon as available in the market.